Journal ArticleOPEN ACCESS

The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers

Familial Cancer (2025) 24(2)
DOI: 10.1007/s10689-025-00457-9
5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) established in 2017 and connecting more than 50 European expert centres improves access to diagnosis, treatment, and the provision of high-quality healthcare for patients with rare genetic tumour risk syndromes (hereditary cancer), no matter where they live in Europe.

Author supplied keywords

Cite

CITATION STYLE

APA

Engels, M., Urbanczyk, K., Hölzenspies, J., Röhl, C., Geverink, N., & Hoogerbrugge, N. (2025). The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers. Familial Cancer, 24(2). https://doi.org/10.1007/s10689-025-00457-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free